DK0690132T3 - Monoklonalt anti-HIV-antistof - Google Patents

Monoklonalt anti-HIV-antistof

Info

Publication number
DK0690132T3
DK0690132T3 DK94909286T DK94909286T DK0690132T3 DK 0690132 T3 DK0690132 T3 DK 0690132T3 DK 94909286 T DK94909286 T DK 94909286T DK 94909286 T DK94909286 T DK 94909286T DK 0690132 T3 DK0690132 T3 DK 0690132T3
Authority
DK
Denmark
Prior art keywords
antibody
region
hiv
pnd
monoclonal antibody
Prior art date
Application number
DK94909286T
Other languages
English (en)
Inventor
Yasuyuki Eda
Hiroaki Maeda
Keiichi Makizumi
Kouichi Shiosaki
Kiyoshi Osatomi
Kazuhiko Kimachi
Hirofumi Higuchi
Sachio Tokiyoshi
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of DK0690132T3 publication Critical patent/DK0690132T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94909286T 1993-03-11 1994-03-09 Monoklonalt anti-HIV-antistof DK0690132T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7891393 1993-03-11
PCT/JP1994/000371 WO1994020632A1 (fr) 1993-03-11 1994-03-09 Anticorps monoclonal dirige contre le vih

Publications (1)

Publication Number Publication Date
DK0690132T3 true DK0690132T3 (da) 2004-04-13

Family

ID=13675093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94909286T DK0690132T3 (da) 1993-03-11 1994-03-09 Monoklonalt anti-HIV-antistof

Country Status (11)

Country Link
US (1) US6114143A (da)
EP (1) EP0690132B1 (da)
JP (1) JP3855071B2 (da)
KR (1) KR100337069B1 (da)
AT (1) ATE256751T1 (da)
AU (1) AU681633B2 (da)
DE (1) DE69433422T2 (da)
DK (1) DK0690132T3 (da)
ES (1) ES2213148T3 (da)
PT (1) PT690132E (da)
WO (1) WO1994020632A1 (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234524A1 (en) * 2001-04-05 2004-11-25 Toshimitsu Uede Anti-osteopontin antibody and use thereof
KR100423614B1 (ko) * 2001-05-16 2004-03-22 주식회사유한양행 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
US7241873B2 (en) 2001-09-25 2007-07-10 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant anti-osteopontin antibody and use thereof
US7195768B2 (en) * 2001-11-07 2007-03-27 Duke University Polyvalent immunogen
WO2003039470A2 (en) 2001-11-07 2003-05-15 Duke University Polyvalent immunogen of hiv
US7172761B2 (en) * 2001-11-07 2007-02-06 Duke University Polyvalent immunogen
US7041499B2 (en) * 2001-12-12 2006-05-09 University Of North Texas Health Science Center Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth
ES2326267T3 (es) * 2002-04-12 2009-10-06 Mba Polymers, Inc. Composiciones de materiales que contienen plasticos reciclados.
WO2003091275A2 (en) * 2002-04-23 2003-11-06 Andrea Savarino Compositions containing anti-hiv peptides and methods of use
JP4922613B2 (ja) * 2003-02-20 2012-04-25 一般財団法人化学及血清療法研究所 モノクローナル抗体製剤の奏効性を向上させる方法
US20050014230A1 (en) * 2003-07-16 2005-01-20 Ccl Holding Co., Ltd. Preparation of fully human antibodies
US7807157B2 (en) 2004-02-20 2010-10-05 Intellect Neurosciences Inc. Monoclonal antibodies and use thereof
EP1934605B1 (en) * 2005-09-22 2014-03-26 Prosci Incorporated Glycosylated polypeptides produced in yeast mutants and methods of use thereof
CA2653661A1 (en) 2006-05-31 2007-12-06 Astellas Pharma Inc. Humanized anti-human osteopontin antibody
RU2503720C2 (ru) 2008-01-11 2014-01-10 Астеллас Фарма Инк. УЛУЧШЕННОЕ ГУМАНИЗИРОВАННОЕ АНТИТЕЛО К ЧЕЛОВЕЧЕСКОМУ α9-ИНТЕГРИНУ
WO2010079850A2 (en) 2009-01-12 2010-07-15 Takeda Pharmaceutical Company Limited Agent for prophylaxis or treatment of cancer
JP5726165B2 (ja) 2010-03-11 2015-05-27 株式会社 資生堂 アオウキクサ由来の新規リポキシゲナーゼ
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
US20130034894A1 (en) 2010-03-31 2013-02-07 Mineyuki Yokoyama Novel allene oxide synthase derived from lemna paucicostata
TW201249867A (en) 2011-04-01 2012-12-16 Astellas Pharma Inc Novel anti-human il-23 receptor antibody
CN103797029B (zh) 2011-05-17 2016-08-17 洛克菲勒大学 人类免疫缺陷病毒中和抗体及其使用方法
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
SI2743348T1 (en) * 2011-08-11 2018-04-30 Astellas Pharma Inc. Novel anti-human ngf antibody
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
TW201333034A (zh) 2011-12-22 2013-08-16 Astellas Pharma Inc 新穎抗人類ｃｔｇｆ抗體
WO2013129454A1 (ja) 2012-02-28 2013-09-06 アステラス製薬株式会社 新規抗ヒトｉｌ－２３受容体抗体
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
UA119328C2 (uk) 2013-08-09 2019-06-10 Астеллас Фарма Інк. Антитіло до тslp-рецептора людини
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
CN109535254B (zh) 2013-12-24 2022-06-24 安斯泰来制药株式会社 抗人bdca-2抗体、其生产方法、多核苷酸、表达载体、宿主细胞及医药组合物
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines
DK4257600T3 (da) 2018-07-03 2025-05-26 Gilead Sciences Inc Antistoffer rettet mod hiv gp120 og fremgangsmåder til at bruge dem
BR112021002096A2 (pt) 2018-08-20 2021-06-01 Jiangsu Hengrui Medicine Co., Ltd. uso de anticorpos tim-3 na preparação de medicamentos para o tratamento de tumores
JP7566257B2 (ja) * 2018-10-29 2024-10-15 株式会社 免疫生物研究所 抗ｈｉｖ抗体及びその製造方法
MY204672A (en) 2018-10-31 2024-09-09 Astellas Pharma Inc Anti-human fn14 antibody
IL322887A (en) 2023-02-27 2025-10-01 Suzhou Suncadia Biopharmaceuticals Co Ltd Anti-DLL3 antibody, antibody-drug conjugate and pharmaceutical use thereof
CN120882753A (zh) 2023-04-13 2025-10-31 江苏恒瑞医药股份有限公司 特异性结合egfr和muc1的抗原结合分子、其药物偶联物及其医药用途
AU2024287056A1 (en) 2023-06-08 2025-12-11 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Anti-npr1 antibody and pharmaceutical use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
DE3853779T2 (de) * 1987-05-29 1995-09-07 Baylor College Medicine Hiv-1 neutralisierende monoklonale antikörper.
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
AU640619B2 (en) * 1988-10-03 1993-09-02 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
WO1990015078A1 (en) * 1989-06-05 1990-12-13 Scott Charles F Jr HUMAN MONOCLONAL ANTIBODIES TO HIV-1MN gp 120
WO1993004090A1 (en) * 1991-08-22 1993-03-04 Nissin Shokuhin Kabushiki Kaisha Hiv immunotherapeutics

Also Published As

Publication number Publication date
DE69433422T2 (de) 2004-09-16
AU6219494A (en) 1994-09-26
ATE256751T1 (de) 2004-01-15
EP0690132A1 (en) 1996-01-03
PT690132E (pt) 2004-04-30
AU681633B2 (en) 1997-09-04
KR960701214A (ko) 1996-02-24
JP3855071B2 (ja) 2006-12-06
KR100337069B1 (ko) 2002-10-11
EP0690132A4 (en) 1998-07-29
EP0690132B1 (en) 2003-12-17
US6114143A (en) 2000-09-05
WO1994020632A1 (fr) 1994-09-15
DE69433422D1 (de) 2004-01-29
ES2213148T3 (es) 2004-08-16

Similar Documents

Publication Publication Date Title
DK0690132T3 (da) Monoklonalt anti-HIV-antistof
RU2432364C2 (ru) ПОЛИКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВ Nogo, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ПРИМЕНЕНИЕ АНТИТЕЛА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА
PT100195A (pt) Anticorpos monoclonais quimericos e humanos que se ligam a epitopos de receptores de factor de crescimento da epiderme, seus vectores de expressao, processo de preparacao e composicoes farmaceuticas que os contem
CA2091263A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
PT678523E (pt) Anticorpos recombinantes anti-vih e sua preparacao
RU94045907A (ru) Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты
DK0492560T3 (da) Human, monoklonale antistoffer rettet imod transmembranglycoproteinet (gp41) af HIV-1 og beslægtede peptider
KR930702509A (ko) 사람 면역결핍 바이러스(hiv)면역치료제
RU2004108115A (ru) Рекомбинантные антитела и композиции, а также способы их создания и использования
ES2059577T3 (es) Fragmentos genicos que codifican para las regiones variables de un anticuerpo anti-hiv, anticuerpos anti-hiv quimericos expresados utilizando los mismos y procedimiento para su preparacion.
ATA171686A (de) Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
DK0516135T3 (da) Humant immundefektvirus-relateret immunpræparat
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
WO1991010742A1 (en) Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
CA2157874A1 (en) Anti-hiv monoclonal antibody
DE69113520D1 (de) Monoklonale Antikörper gegen HIV GP120.
US20240247051A1 (en) Methods of immunotherapy
RU2007140569A (ru) Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич, но не в отношении il2
Huang et al. A predefined epitope-specific monoclonal antibody recognizes ELDEWA-epitope just presenting on gp41 of HIV-1 O clade
KR20040000401A (ko) Ｈｉｖ 바이러스에 대한 천연 항체
DK0470989T3 (da) Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer
WO2024123897A1 (en) Broadly neutralizing and potent antibodies against hiv
JP3780421B2 (ja) ヒト免疫不全ウイルスに対するワクチンおよびその製造方法
RU2021136626A (ru) АНТИТЕЛО К EphA4